To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
Generally in CEA, but even more the Institute of life sciences Frédéric Joliot, researchers have a true culture of valuing their research project. This is manifested by filing patents on original targets, new molecules or pharmacological action on copyrightable skills. It is also reflected in the ongoing search for industrial partnerships and, for some researchers, it is moving towards the creation of start-ups.
+33 (0)1 69 08 72 firstname.lastname@example.org
When projects have reached a sufficient level of development to be transferred to an industrial partner, our role is to identify the right partner, present the project and the team, and then accompany the transfer of technology (contracting, monitoring milestones, balance sheet ...).
If you are an industrialist looking for specific patents and / or know-how in the fields of chemistry, biology or pharmacology, contact-us.
Many researchers, engineers and technicians of the Institute, have a long experience of collaborations with leading pharmaceutical, chemical, biotechnology and diagnostics industrials. This experience is reflected in the number of industrial laboratories working with our teams and also by the desire to offer a recognized unit. In this regard, the Pharmacology and Immunoanalysis Unit is ISO9001 certified.Of course, industrial partnerships vary from one partner to another.In general, they can take the form of a development partnership associated with a transfer of technology, an R & D collaboration with a license option on Industrial Property or, more upstream, via a thesis contract CIFRE. We invite you to contact us to set-up a collaborative project..
Currently, several development projects are carried out within our institute in the fields of pharmaceuticals or diagnostic tests, jointly with an industrialist or an investor (private or public).
The teams of the Frédéric Joliot institute possessing a know-how and / or a certified platform, can also carry out various studies via service contracts. We already have a strong experience and a recognized expertise in the fields presented in the image.
Some collaborations are realized through hosting in our institute premises, in companies or academic research units.For example, within the Pharmacology and Immunoanalysis Unit, three teams of partner companies are hosted for R&D collaboration.
The Institute Frédéric Joliot has a culture of business creation mainly in chemistry and pharmacology. Former doctoral candidates have thus created SYNDIVIA, specialized in the bio-conjugation of antibodies with anticancer molecules. Other researchers are involved in the creation of start-ups, such as H-IMMUNE, while continuing their scientific activity and thus entrusting the start-up assembly to an external bearer.If you are willing to set up a company in the fields of biology / chemistry / pharmacology, we suggest you to contact us to evaluate our opportunities together.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.